Table 5 Regression analysis (enter model) for prognostic factors that determine non-adherence

Treatment sessions (> 6) (n = 163)

40

Gender (f/m)

3.89

1.41 – 10.72

0.009

Sport (y/n)

2.66

0.73 – 9.68

0.14

Load in ADL (high/low)

1.75

0.51 – 6.02

0.38

Recurrent sprain (y/n)

6.90

2.34 – 20.37

< 0.001

Other pathology (y/n)

25.92

6.79 – 98.93

< 0.001

Function score (< 75) (n = 163)

12

Function score begin (0–100)

0.99

0.95 – 1.05

0.95

Pain (0–35)

0.81

0.67 – 0.97

0.89

Treatment goals phase 1 not accomplished (n = 68)

23

Function score begin (0–100)

1.01

0.86 – 1.18

0.95

Pain (0–35)

0.76

0.53 – 1.10

0.15

Dynamic stability (0–25)

0.85

0.62 – 1.16

0.30

Treatment goals phase 2 not accomplished (n = 74)

18

Swelling (0–10)

0.66

0.49 – 0.91

0.01